人工智能从产生的第一天起,就与医学密不可分。人工智能在医疗领域的应用带来的不仅有技术革新,还有医疗服务模式的转变。人工智能可以在医疗行业多个环节发挥作用,如医学影像、健康管理、疾病风险预测、虚拟助理、药物设计、临床诊疗等。我国近年来发布了针对人工智能发展的系列政策规划,2017年更从国家战略层面积极支持人工智能发展,其中,关于医疗人工智能的政策是重点内容之一。我国医疗人工智能领域外文科技论文和专利申请、专利公开都呈现逐年增长的趋势。2018年医疗人工智能行业整体投资处在加速阶段,但随之而来的伦理风险不容忽视。我国医疗人工智能的发展面临诸多挑战,包括政策监管滞后、高端专业技术人才少、高质量数据不足、商业运营模式不确定、法律与伦理研究存在空白等。本报告认为,人工智能在医学领域的应用将越来越广泛,部分产品将正式获得批准成为医疗器械,监管将越来越规范和严格。
<<From the first day AI was begotten,AI and medicine were closely entwined. The application of artificial intelligence in the medical field brings not only technological innovation,but also the transformation of the medical service model. Artificial intelligence plays a role in many aspects of the medical industry,such as medical imaging,health management,disease risk prediction,virtual assistants,drug design,clinical diagnosis and treatment.
In recent years,China has released a series of policy plans for the development of artificial intelligence. In 2017,it has risen to the national strategic level and actively supports the development of artificial intelligence. Among them,the policy on medical artificial intelligence is one of its key contents. The foreign language scientific papers,patent applications and patent publications in the field of medical artificial intelligence in China all show a trend of increasing year by year. In 2018,the overall investment in the medical artificial intelligence industry is in an accelerated phase. The ethical risks that come with artificial intelligence cannot be ignored.
The development of medical artificial intelligence in China faces many challenges,including lagging policy supervision,low-level professional and technical talents,insufficient high-quality data,uncertain business operation models,and legal and ethical research gaps. This report divulges that the application of artificial intelligence in the medical field will become increasingly extensive,some products will be formally approved as medical devices,and supervision will become more and more standardized and strict.
<<